Tech Company Financing Transactions
Vitae Pharmaceuticals Funding Round
On 7/13/2005, Vitae Pharmaceuticals announced $15 million in funding from Atlas Venture, Intel Capital and New Enterprise Associates.
Transaction Overview
Company Name
Announced On
7/13/2005
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds principally to accelerate its multiple programs into the clinic.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
502 West Office Center Dr.
Fort Washington, PA 19034
USA
Fort Washington, PA 19034
USA
Phone
Website
Email Address
Overview
Vitae Pharmaceuticals (NADAQ: VTAE) is developing a robust and growing portfolio of novel product candidates generated by Contour, our proprietary computationally-based SBDD platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Hatfield
Chief Financial Officer
Richard Morris
Chief Medical Officer
Carole Sable
Chief Scientific Officer
Richard Gregg
VP - Bus. Development
Arthur Fratamico
Browse more venture capital transactions:
Prev: 7/13/2005: Omniture venture capital transaction
Next: 7/14/2005: Bradford Networks venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs